Delivery Order SPE2DR25D3801-SPE2DR26F6QDR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,870.88 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count) on December 11, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order, valued at $3,972.54, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 with a ceiling value of $1,332.72. This competitively awarded, firm fixed-price delivery order is set to be completed by December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, the award reflects AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $1,999.56 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 5 mg tablets (30-count packaging). The contract was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units, with a ceiling value of $8,774.89. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,149.25 for Dapagliflozin 5 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, valued at $1,198.39. This non-competitive, firm fixed-price delivery order was awarded without a set-aside designation and is scheduled for completion by November 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,357.78 for 30-tablet units of Dapagliflozin 5 mg, a diabetes medication. This non-set-aside, competitively awarded contract was executed on November 6, 2025, with an ultimate completion date of November 7, 2025. The firm fixed price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dapagliflozin 5 mg tablets in 30-count packages, with a ceiling value of $1,401.85 and an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 tablets, valued at $5,141.86 under a firm fixed price contract. This delivery order represents a non-set-aside competitive award and is scheduled for completion by August 11, 2025. The products will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QDRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,074.12 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units. This contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and utilized firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement reflects the company's established role as a critical vendor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/10/25 |